14
Hugel
145020.KQ·KOSDAQChuncheon KRFounded 2001400 employees
Mid CapbiotechPublicDermatology
Platform: Botulinum
Market Cap
$2B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (145020.KQ)
Loading 145020.KQ stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Voxafotisoran | 145-4958 | Phase 3 | 1 | JAK1 | GBMMM | ||
| 145-403 | 145-403 | Phase 1/2 | 1 | KRASG12D | Atopic Derm |
SEC Filings & Financial Documents
SEC filings are not available for KOSDAQ-listed companies.
Hugel trades on KOSDAQ (KR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)